SCHEMBL21362518

SCHEMBL21362518

Cn1cc(-c2ccccc2C(=O)c2ccc(Cl)cc2)c(C(N)CC(=O)OC(C)(C)C)cc1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.45
KDM4E B2RXH2 3/20 0.37
PTPRC P08575 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ABCB11 O95342 1/20 0.34
PTGS2 P35354 1/20 0.34
NR4A1 P22736 1/20 0.33
P2RX3 P56373 1/20 0.33
MEN1 O00255 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157788 0.87 BRD4 (0.43) BRD4KDM4EPTPRCKMT2AMAPT
SCHEMBL21362517 0.83 BRD4 (0.40) BRD4KDM4EPTPRCKMT2AP2RX3
SCHEMBL21362150 0.83 BRD4 (0.40) BRD4KDM4EPTPRCKMT2AP2RX3
SCHEMBL21362559 0.78 BRD4 (0.52) BRD4KDM4EKMT2AMAPTALDH1A1
SCHEMBL21362563 0.77 BRD4 (0.53) BRD4KDM4EKMT2AMAPTALDH1A1
SCHEMBL20157810 0.76 BRD4 (0.46) BRD4KDM4EKMT2AALDH1A1LMNA
SCHEMBL21352026 0.76 BRD4 (0.48) BRD4KDM4EKMT2AMAPTALDH1A1
SCHEMBL21351879 0.76 BRD4 (0.50) BRD4KDM4EKMT2AMAPTALDH1A1
SCHEMBL21362103 0.74 BRD4 (0.46) BRD4KDM4EKMT2AMAPTALDH1A1
SCHEMBL27536809 0.74 GABRP (0.40) MAPTLMNAHTTGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed